Русский
Modern aspects of detection and monitoring of preclinical stages of type 1 diabetes mellitus in children
DOI: https://dx.doi.org/10.18565/pharmateca.2025.2.20-25
T.V. Varlamova, N.N. Vezikova
Petrozavodsk State University, Petrozavodsk, Russia
Type 1 diabetes mellitus (DM1) is one of the most common endocrine diseases in children. DM1 develops as a result of the interaction of a predisposing genetic background and epigenetic factors. Identification of patients at risk of developing DM1 is the key to developing strategies to prevent the development of the disease. Autoantibody-based screening provides information on the current DM1 stage, the time before the risk of developing stage 3 DM1. The introduction of screening for DM1 has potential benefits, namely, a decrease in the development of diabetic ketoacidosis, a decrease in stress on the part of parents and children when making a diagnosis, and the possibility of better psychological adaptation.
About the Autors
Tatyana V. Varlamova, Cand. Sci. (Med.), Associate Professor, Petrozavodsk State University, Medical Institute named after prof. A.P. Zilber, Petrozavodsk, Russia; varlamova@sampo.ru, examlpe@address.ru, ORCID: https://orcid.org/0000-0001-5617-8893, Scopus Author
ID: 58819203900 (corresponding author)
N.N. Vezikova, Petrozavodsk State University, Petrozavodsk, Russia; ORCID: https://orcid.org/0000-0002-8901-3363, Scopus Author
ID: 6505871479
Similar Articles
